[1]. B A Mahal, et al. High PSA anxiety and low health literacy skills: drivers of early use of salvage ADT among men with biochemically recurrent prostate cancer after radiotherapy?. Ann Oncol. 15 Jul;6(7):139-5.
[]. Christopher J Sweeney, et al. Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer. N Engl J Med. 15 Aug ;373(8):737-46.
[3]. Feng Sun, et al. A novel prostate cancer therapeutic strategy using icaritin-activated arylhydrocarbon-receptor to co-target androgen receptor and its splice variants. Carcinogenesis. 15 Jul;36(7):757-68.
[4]. Florence K Keane, et al. Androgen deprivation therapy and the risk of death from prostate cancer among men with favorable or unfavorable intermediate-risk disease. Cancer. 15 Aug 15;11(16):713-9.
[5]. Mischa T Rijnierse, et al. Clinical Impact of Cardiac Magnetic Resonance Imaging Versus Echocardiography-Guided Patient Selection for Primary Prevention Implantable Cardioverter Defibrillator Therapy. Am J Cardiol. 15 Aug 1;116(3):46-1.
H3-H413
P64-P7-P73-P33-P51
GHS7